REFERENCES
- Al-Jaroudi W. A., Salti N. N., Usta J. A., Zwainy D. S., Karam C. N., Bikhazi A. B. Effect of insulin and angiotensin II receptor subtype-1 antagonist on myocardial remodeling in rats with insulin-dependent diabetes mellitus. Journal of Hypertension 2005; 23: 381–392, [PUBMED], [INFOTRIEVE], [CSA]
- Battistini B, D′Orleans-Juste P, Sirois P. Biology of disease. Endothelins: Circulating plasma levels and presence in other biologic fluids. Laboratory Investigation 1993; 68: 600–628, [PUBMED], [INFOTRIEVE], [CSA]
- Berthiame N, Cliang A, Regoli D, Warner T. D., D′Orleans-Juste P. Characterization of receptors for kinins and neurokinins in the arterial and venous mesenteric vasculatures of the guinea-pig. British Journal of Pharmacology 1995; 115: 1319–1325, [CSA]
- Bikhazi A. B., Khalifeh A. M., Jaroudi W. A., Saadeddine R. E., Jurjus A. R., El-Sabban M. E., Bitar K. M. Endothelin-1 receptor subtypes expression and binding in a perfused rat model of myocardial infarction. Comparative Biochemistry and Physiology Part C 2003; 134: 35–43, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chandramouli V, Carter J. R., Jr. Cell membrane changes in chronically diabetic rats. Diabetes 1975; 24: 257–262, [PUBMED], [INFOTRIEVE], [CSA]
- Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S. Diabetes-induced myocardial structural changes: Role of endothelin-1 and its receptors. Journal of Molecular and Cellular Cardiology 2000; 32: 1621–1629, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chua B. H., Chua C. C., Diglio C. A., Siu B. B. Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells. Biochimica et Biophysica Acta 1993; 1178: 201–206, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Clauser E. Molecular structure and function of angiotensin II receptors. Nephrologie 1998; 19: 403–10, [PUBMED], [INFOTRIEVE], [CSA]
- Dhein S, Hochreuther S, Aus Dem Spring C, Bollig K, Hufnagel C, Raschack M. Long-term effects of the endothelin (A) receptor antagonist LU135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model. Journal of Pharmacology and Experimental Therapeutics 2000; 293: 351–359, [PUBMED], [INFOTRIEVE], [CSA]
- Emori T, Hirata Y, Ohta K, Kanno K, Eguchi S, Imai T, Shichiri M, Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension 1991; 18: 165–170, [PUBMED], [INFOTRIEVE], [CSA]
- Filep J. G., Foldes-Filep E, Rousseau A, Fournier A, Sirois P, Yano M. Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptors. European Journal of Pharmacology 1992; 219: 343–344, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fiordaliso F, Li B, Latini R, Sonnenblick E. H., Anversa P, Leri A, Kajstura J. Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Laboratory Investigation 2000; 80: 513–527, [PUBMED], [INFOTRIEVE], [CSA]
- Folli F, Kahn C. R., Hansen H, Bouchie J. L., Feener E. P. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. Journal of Clinical Investigation 1997; 100: 2158–2169, [PUBMED], [INFOTRIEVE], [CSA]
- Frelin C, Guedin D. Why are circulating concentrations of endothelin-1 so low?. Cardiovascular Research 1994; 28: 1613–1622, [PUBMED], [INFOTRIEVE], [CSA]
- Fukuda G, Khan Z, Barbin Y. P., Chakrabarti S, Tilton R. Role of endothelins in diabetes-induced extracellular matrix protein production and increased medial thickness in rat aorta (dyslipidemia and atheroscleorsis). Diabetes 2003; 52: A74, (1)[CSA]
- Haddad R. E., Jurjus A. R., Ibrahim M. Z.M., Nahlè Z. A., El-Kasti M. M., Bitar K. M., Kreydiyyeh S. I., Saadeh F. A., Bikhazi A. B. Binding of [125I]-Insulin on capillary endothelial and myocytes cell membranes in normal and streptozotocin-induced diabetic rat hearts. Comparative Biochemistry and Physiology 1997; 177A: 523–530, [CSA]
- Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, Marumo F. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. Journal of Clinical Investigation 1993; 91: 1367–1373, [PUBMED], [INFOTRIEVE], [CSA]
- Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proceedings of the National Academy of Sciences of the United States of America 1989; 86: 2863–2867, [PUBMED], [INFOTRIEVE], [CSA]
- Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Murumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. Journal of Clinical Investigation 1993; 92: 398–403, [PUBMED], [INFOTRIEVE], [CSA]
- Jiang Z. Y., Zhou Q, Chatterjee A, Feener E. P., Myers M. G., Jr., White M. F., King G. L. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 1999; 48: 1120–1130, [PUBMED], [INFOTRIEVE], [CSA]
- Masaki T. The discovery of endothelins. Cardiovascular Research 1998; 39: 530–533, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McEwan P. E., Sherry L, Kenyon C. J., Webb D. J., Gray G. A. Regulation of the myocardial endothelin system by angiotensin II and losartan. Journal of Cardiovascular Pharmacology 2000; 36(5)S144–S147, Suppl. 1[PUBMED], [INFOTRIEVE], [CSA]
- Mitchell D, Bihari A, Sandig M, Tyml K. Endothelin-A receptor in rat skeletal muscle microvasculature. Microvascular Research 2002; 64: 179–185, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Oliver F. J., de la Rubia G, Feener E. P., Lee M. E., Loeken M. R., Shiba T, Quertermous T, King G. L. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. Journal of Biological Chemistry 1991; 266: 23251–23256, [PUBMED], [INFOTRIEVE], [CSA]
- Ono K, Tsujimoto G, Sakamoto A, Eto K, Masaki T, Osaki Y, Satake M. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature 1994; 370: 301–304, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Park J. Y., Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha S. W., Meier M, Rhodes C. J., King G. L. Induction of endothelin-1 expression by glucose. An effect of protein kinase C activation. Diabetes 2000; 49: 1239–1248, [PUBMED], [INFOTRIEVE], [CSA]
- Ponicke K, Heinroth-Hoffmann I, Becker K, Brodde O. E. Trophic effect of angiotensin II in neonatal rat cardiomyocytes: Role of endothelin-1 and non-myocyte cells. British Journal of Pharmacology 1997; 121: 118–124, [PUBMED], [INFOTRIEVE], [CSA]
- Rubanyi G. M., Polokoff M. A. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacological Reviews 1994; 46: 325–415, [PUBMED], [INFOTRIEVE], [CSA]
- Sakurai T, Morimoto H, Kasuya Y, Takuwa Y, Nakauchi H, Masaki T, Goto K. Level of ETB receptor mRNA is down-regulated by endothelins through decreasing the intracellular stability of mRNA molecules. Biochemical and Biophysical Research Communications 1992; 186: 342–347, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sechi L. A., Griffin C. A., Schambelan M. The cardiac renin-angiotensin system in STZ-induced diabetes. Diabetes 1994; 43: 1180–1184, [PUBMED], [INFOTRIEVE], [CSA]
- Sokolovsky M, Ambar I, Galron R. A novel subtype of endothelin receptors. Journal of Biological Chemistry 1992; 267: 20551–2054, [PUBMED], [INFOTRIEVE], [CSA]
- Teerlink J. R. Reversal of left ventricular remodeling: Role of the endothelin pathway. Journal of Cardiac Failure 2002; 8: S494–S499, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thomas G. P., Sims S. M., Karmazyn M. Differential effects of endothelin-1 on basal and isoprenaline-enhanced Ca2 + current in guinea-pig ventricular myocytes. Journal of Physiology 1997; 503: 55–65, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vesci L, Mattera G. G., Tobia P, Corsico N, Calvani M. Cardiac and renal endothelin-1 binding sites in streptozotocin-induced diabetic rats. Pharmacological Research 1995; 32: 363–367, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wendel-Wellner M, Noll T, König P, Schmeck J, Koch T, Kummer W. Cellular localization of the endothelin receptor subtypes ETA and ETB in the rat heart and their differential expression in coronary arteries, veins, and capillaries. Histochemistry and Cell Biology 2002; 118: 361–369, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wollesen F, Berglund L, Berne C. Plasma endothelin-1 and total insulin exposure in diabetes mellitus. Clinical Science 1999; 97: 149–56, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yangisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yakazi Y, Gotto K, Masaki T. 1988; 332: 411–415, [CSA]